Construction and characterization of genetically-marked bivalent anti-Shigella dysenteriae 1 and anti-Shigella flexneri Y live vaccine candidates

Microbial Pathogenesis

Volumn 22, Issue 6, 1997, Pages 363-376

  Klee, Silke R ^a   Tzschaschel, Barbara D ^a   Singh, Mahavir ^a   Fält, Inger ^b   Lindberg, Alf A ^b   Timmis, Kenneth N ^a   Guzmán, Carlos A ^a  

^a HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

LPS; O antigen; Shigella dysenteriae serotype 1; Shigellosis; Vaccine

Indexed keywords

LIPOPOLYSACCHARIDE; LIVE VACCINE; SHIGELLA VACCINE;

ARTICLE; PRIORITY JOURNAL; SEROTYPING; SHIGELLA DYSENTERIAE; SHIGELLA FLEXNERI; SHIGELLOSIS;

EID: 0030918570     PISSN: 08824010     EISSN: None     Source Type: Journal    
DOI: 10.1006/mpat.1996.0127     Document Type: Article

References (56)

1. Katz S.L. The prospects for immunizing againstShigellaInstitute of Medicine. New Vaccine Development: Establishing Priorities. Diseases of Importance in Developing Countries. Washington DC: National Academy Press. 2:1986;329-337.
2. DuPont H.L., Levine M.M., Hornick R.B., Formal S.B. Inoculum size in shigellosis and implications for expected mode of transmission. J Infect Dis. 159:1989;1126-1128.
3. Levine M.M. Bacillary dysentery. Mechanisms and treatment. Med Clin North Amer. 66:1982;623-638.
4. Casalino M., Nicoletti M., Salvia A., Colonna B., Pazzani C., Calconi A., Mohamud K.A., Maimone F. Characterization of endemicShigella flexneri. J Clin Microbiol. 32:1994;1179-1183.
5. Levine M., Gangarosa E.J., Werner M., Morris G.K. Shigellosis in custodial institutions. J Pedia. 84:1974;803-806.
6. Robbins J.B., Chu C., Schneerson R. Hypothesis for vaccine development: protective immunity to enteric diseases caused by nontyphoidealSalmonellaShigella. Clin Infect Dis. 15:1992;346-361.
7. Formal S.B., Maenza R.M., Austin S., LaBrec E.H. Failure of parenteral vaccines to protect monkeys against experimental shigellosis. Proc Soc Exp Biol Med. 25:1967;347-349.
8. Hale T.L., Keren D.F. Pathogenesis and immunology in shigellosis: applications for vaccine development. In: Sansonetti PJ,Ed. Current Topics in Microbiology and Immunology. 180:1992;117-137.
9. Lindberg A.A., Pál T. Strategies for development of potential candidateShigella vaccines. Vaccine. 11:1993;168-179.
10. Baron L.S., Kopecko D.J., Formal S.B., Seid R., Guerry P., Powell C. Introduction ofShigella flexneriSalmonella typhi. Infect Immun. 55:1987;2797-2801.
11. Formal S.B., Baron L.S., Kopecko D.J., Washington O., Powell C., Life C.A. Construction of a potential bivalent vaccine strain: introduction ofShigella sonneigalE Salmonella typhi. Infect Immun. 34:1981;746-750.
12. Seid R.C., Kopecko D.J., Sadoff J.C., Schneider H., Baron L.S., Formal S.B. Unusual lipopolysaccharide antigens of aSalmonella typhiShigella sonnei. J Biol Chem. 259:1984;9028-9034.
13. Tramont E.C., Chung R., Berman S., Keren D., Kapfer C., Formal S.B. Safety and antigenicity of typhoid-Shigella sonnei. J Infect Dis. 149:1984;133-136.
14. Viret J-F, Cryz SJ Jr, Lang A.B., Favre D. Molecular cloning and characterization of the genetic determinants that express the completeShigellaShigella sonnei. Mol Microbiol. 7:1993;239-252.
15. Lindberg A.A., Kärnell A., Pál T., Sweiha H., Hultenby K., Stocker B.A.D. Construction of an auxotrophicShigella flexneri. Microb Pathog. 8:1990;433-440.
16. Kärnell A., Stocker B.A.D., Katakura S., Reinholt F.P., Lindberg A.A. Live oral auxotrophicShigella flexneriaro. Vaccine. 10:1992;389-394.
17. Li A., Pál T., Forsum U., Lindberg A.A. Safety and immunogenicity of the live oral auxotrophicShigella flexneri. Vaccine. 10:1992;395-404.
18. Li A., Kärnell A., Huan P.T., Cam P.D., Minh N.B., Tram L.N., Quy N.P., Trach D.D., Karlsson K., Lindberg G., Lindberg A.A. Safety and immunogenicity of the live oral auxotrophicShigella flexneri. Vaccine. 11:1993;180-189.
19. Li A., Cam P.D., Islam D., Minh N.B., Huan P.T., Rong Z.C., Karlsson K., Lindberg G., Lindberg A.A. Immune responses in Vietnamese children after a single dose of the auxotrophic, liveShigella flexneri. J Infection. 28:1994;11-23.
20. Hartman A.B., Powell C.J., Schultz C.L., Oaks E.V., Eckels K.H. Small-animal model to measure efficacy and immunogenicity ofShigella. Infect Immun. 59:1991;4075-4083.
21. Kärnell A., Sweiha H., Lindberg A.A. Auxotrophic live oralShigella flexneriS. flexneri. Vaccine. 10:1992;167-174.
22. Mallett C.P., VanDeVerg L., Collins H.H., Hale T.L. Evaluation ofShigella. Vaccine. 11:1993;190-196.
23. Watanabe H., Timmis K.N. A small plasmid inShigella dysenteriae. Infect Immun. 43:1984;391-396.
24. Hale T.L., Guerry P., Seid R.C., Kapfer C., Wingfield M.E., Reaves C.B., Baron L.S., Formal S.B. Expression of lipopolysaccharide O antigen inEscherichia coliShigella dysenteriae. Infect Immun. 46:1984;470-475.
25. Sturm S., Jann B., Jann K., Fortnagel P., Timmis K.N. Genetic and biochemical analysis ofShigella dysenteriaerfb. Microb Pathog. 1:1986;307-324.
26. Sturm S., Timmis K.N. Cloning of therfbShigella dysenteriaerfp-rfb. Microb Pathog. 1:1986;289-297.
27. Mills S.D., Sekizaki T., Gonzalez-Carrero M.I., Timmis K.N. Analysis and genetic manipulation ofShigella. Vaccine. 6:1988;116-122.
28. Herrero M., de Lorenzo V., Timmis K.N. Transposon vectors containing non-antibiotic resistance selection markers for cloning and stable chromosomal insertion of foreign genes in gram-negative bacteria. J Bacteriol. 172:1990;6557-6567.
29. Fält I.C., Schweda E.K.H., Klee S., Singh M., Floderus E., Timmis K.N., Lindberg A.A. Expression ofShigella dysenteriaeShigella flexneri aroDS. flexneri. J Bacteriol. 177:1995;5301-5305.
30. Sansonetti P.J., Kopecko D.J., Formal S.B. Involvement of a plasmid in the invasive ability ofShigella flexneri. Infect Immun. 35:1982;852-860.
31. Hale T.L. Genetic bases of virulence inShigella. Microbiol Rev. 55:1991;206-224.
32. Sasakawa C., Buysse J.M., Watanabe H. 1992. The large virulence plasmid ofShigella. Current Topics in Microbiology and Immunology. 180:1992;21-44.
33. Sansonetti P.J., Mounier J. Metabolic events mediating early killing of host cells infected byShigella flexneri. Microb Pathog. 3:1987;53-61.
34. Lindberg A.A., Kärnell A., Weintraub A. The lipopolysaccharide ofShigella. Rev Infect Dis. 13:1991;S279-84.
35. Goldberg M.B., Sansonetti P.J. Shigella. Infect Immun. 61:1993;4941-4946.
36. Programme for control of diarrhoeal diseases, seventh programme report, 1988-1989. Document WHO/CDD/90.34. Geneva: World Health Organization. 1990.
37. Batchelor R.A., Alifano P., Biffali E., Hull S.I., Hull R.A. Nucleotide sequences of the genes regulating O-polysaccharide antigen chain length (rolEscherichia coliSalmonella typhimurium. .J Bacteriol. 174:1992;5228-5236.
38. Klena J.D., Schnaitman C.A. Function of therfbrfeShigella dysenteriae. Mol Microbiol. 9:1993;393-402.
39. qPtrp-lac. Gene. 123:1993;17-24.
40. Fellay R., Frey J., Krisch H. Interposon mutagenesis of soil and water bacteria: a family of DNA fragments designed for in vitro insertional mutagenesis of Gram-negative bacteria. Gene. 52:1987;147-154.
41. Kruezer K., Pratt C., Torriani A. Genetic analysis of regulatory mutants of alkaline phosphatase ofE. coli. Genetics. 81:1975;459-468.
42. Sambrook J., Fritsch E.F., Maniatis T. Molecular Cloning: a Laboratory Manual. Cold Spring Harbor Laboratory Press. 1989.
43. O'Callaghan D., Charbit A. High efficiency transformation ofSalmonella typhimuriumSalmonella typhi. Mol Gen Genet. 223:1990;156-158.
44. Hitchcock P.J., Brown T.M. Morphological heterogeneity amongSalmonella. J Bacteriol. 154:1983;269-277.
45. Lesse A.J., Campagnari A.A., Bittner W.E., Apicella M.A. Increased resolution of lipopolysaccharides and lipooligosaccharides utilizing tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis. J Immunol Meth. 126:1990;109-117.
46. Tsai C-M, Frasch C.E. A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels. Anal Biochem. 119:1982;115-119.
47. Islam D., Lindberg A.A. Detection ofShigella dysenteriaeShigella flexneri. J Clin Microbiol. 30:1992;2801-2806.
48. Richards E. Preparation of genomic DNA from bacteria. Miniprep of bacterial genomic DNA, unit 2.4.1. In: Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K, Eds. Current Protocols in Molecular Biology. 1987;1-2.
49. Kado C.I., Liu S-T. Rapid procedure for detection and isolation of large and small plasmids. J Bacteriol. 145:1981;1365-1373.
50. Halling S.M., Simons R.W., Way J.C., Walsh R.B., Kleckner N. DNA sequence organization of IS101010. Proc Natl Acad Sci USA. 79:1982;2608-2612.
51. Klena J.D., Ashford RS II., Schnaitman C.A. Role ofEscherichia colirfarfpShigella dysenteriae. J Bacteriol. 174:1992;7297-7307.
52. Göhmann S., Manning P.A., Alpert C-A, Walker M.J., Timmis K.N. Lipopolysaccharide O-antigen biosynthesis inShigella dysenteriaerfp. Microb pathog. 16:1994;53-64.
53. Chen C-M, Misra T.K., Silver S., Rosen B.P. Nucleotide sequence of the structural genes for an anion pump. The plasmid-encoded arsenical resistance operon. J Biol Chem. 261:1986;15030-15038.
54. Tzschaschel B.D., Klee S.R., de Lorenzo V., Timmis K.N., Guzmán C.A. Towards a vaccine candidate againstShigella dysenteriaeShigella flexneri aroD. Microb Pathog. 21:1996;277-288.
55. Carlin N.I.A., Bundle D.R., Lindberg A.A. Characterization of fiveShigella flexneri. J Immunol. 138:1987;4419-4427.
56. Westphal O., Jann K. plications of the procedure. Methods Carbohydr Chem. 5:1965;83-91.